IRIS
VITALE, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.629
EU - Europa 7.394
AS - Asia 2.497
SA - Sud America 153
Continente sconosciuto - Info sul continente non disponibili 39
AF - Africa 16
OC - Oceania 8
Totale 24.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.607
RU - Federazione Russa 2.431
UA - Ucraina 1.524
CN - Cina 1.016
VN - Vietnam 776
GB - Regno Unito 713
SE - Svezia 667
IT - Italia 629
DE - Germania 605
SG - Singapore 595
FR - Francia 467
FI - Finlandia 141
BR - Brasile 131
NL - Olanda 63
EU - Europa 39
PL - Polonia 37
IE - Irlanda 27
HK - Hong Kong 24
JP - Giappone 24
BE - Belgio 19
IN - India 15
CA - Canada 14
AT - Austria 13
AR - Argentina 8
AU - Australia 7
MA - Marocco 7
ES - Italia 6
GR - Grecia 6
TR - Turchia 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
IQ - Iraq 5
LU - Lussemburgo 5
MX - Messico 5
PT - Portogallo 5
ZA - Sudafrica 5
CH - Svizzera 4
DK - Danimarca 4
EC - Ecuador 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
IR - Iran 3
KR - Corea 3
KZ - Kazakistan 3
PK - Pakistan 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
HR - Croazia 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
PE - Perù 2
RO - Romania 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BT - Bhutan 1
CL - Cile 1
CY - Cipro 1
EE - Estonia 1
GH - Ghana 1
ID - Indonesia 1
IL - Israele 1
LK - Sri Lanka 1
LT - Lituania 1
MC - Monaco 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
SA - Arabia Saudita 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 24.736
Salva come PNG Salva come JPEG
Città #
Fairfield 2.107
Woodbridge 1.882
Houston 1.678
Ann Arbor 1.318
Wilmington 1.050
Ashburn 913
Chandler 897
Seattle 840
Dong Ket 774
Cambridge 688
Dearborn 535
Nyköping 441
Jacksonville 426
Shenzhen 395
Southend 392
Moscow 378
Boardman 283
Singapore 211
Beijing 197
Lawrence 152
Princeton 151
Ogden 108
Shanghai 106
New York 91
San Diego 74
Grafing 69
Norwalk 63
Düsseldorf 62
Naples 60
London 51
Des Moines 49
Groningen 49
Yubileyny 44
Los Angeles 40
Falls Church 39
Nanjing 36
Rome 36
Kraków 34
Jinan 31
Dublin 26
Munich 24
Hong Kong 23
Bergamo 22
Shenyang 22
Hefei 19
Napoli 19
Brussels 18
Nanchang 18
Edinburgh 17
Milan 17
Santa Clara 17
Auburn Hills 15
Redwood City 15
Bremen 14
Kunming 14
Helsinki 13
Washington 13
Kilburn 12
Tokyo 12
Dallas 11
Florence 11
Vienna 11
Guangzhou 10
Lauterbourg 10
New Bedfont 10
Zhengzhou 10
Tappahannock 9
Bari 8
Changsha 8
Hangzhou 8
Hebei 8
Matawan 8
Ningbo 8
Nürnberg 8
São Paulo 8
Wandsworth 8
Amsterdam 7
Chicago 7
Chiswick 7
Haikou 7
Hounslow 7
Lanzhou 7
Tianjin 7
Catania 6
Council Bluffs 6
Fukushima 6
Rio de Janeiro 6
Succivo 6
Taizhou 6
Acton 5
Boston 5
Clifton 5
Greenville 5
Montreal 5
Sofia 5
St Louis 5
Stockholm 5
Atlanta 4
Baotou 4
Caserta 4
Totale 17.391
Salva come PNG Salva come JPEG
Nome #
Progressive parkinsonism, balance difficulties, and supranuclear gaze palsy 597
Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding. 272
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 267
Effects of Global Postural Reeducation on gait kinematics in parkinsonian patients: a pilot randomized three-dimensional motion analysis study 265
Reliability and validity of Italian version of the Dimensional Apathy Scale in Parkinson’s Disease 241
Common mutations in the LRRK2 exon 41 are not responsible for essential tremor in Italian patients 239
Cognitive and affective theory of mind in patients with essential tremor 237
Hearing Impairment in Parkinson’s Disease: Expanding the Non-Motor Phenotype 234
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 234
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 229
Apathy and related Executive Syndromes in Dementia associated with Parkinson’s Disease and in Alzheimer’s Disease 227
Apathy in untreated, de novo patients with Parkinson's disease: validation study of Apathy Evaluation Scale 220
DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients 219
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 213
Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions 212
Abnormal eating behaviors in progressive supranuclear palsy 209
Apathy in Parkinson’s Disease: diagnosis, neuropsychological correlates, pathophysiology and treatment 207
Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia 206
Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients 206
Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients 206
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 204
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 203
Effects of physical rehabilitation on gait pattern in parkinsonian patients with lateral trunk flexion: a three dimensional motion analysis investigation 198
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease 198
Impact of cognitive tasks on kinematic gait parameters in FTD patients 197
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 197
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients 195
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients 195
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease 195
The role of embodied simulation in mental transformation of whole-body images: evidence from Parkinson's disease 195
How does smoking affect olfaction in Parkinson's disease? 194
Affective theory of mind in patients with Parkinson's disease: comment 193
Parkinson’s patients with or without MCI classified according to wavelet analysis of lower limb joint angles in gait cycle 189
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations 189
Gender and non motor fluctuations in Parkinson's disease: a prospective study 188
Pathological gambling in Parkinson's disease. A comprehensive review 187
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 187
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 187
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 186
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 186
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. 186
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 185
Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages 185
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 184
Teaching NeuroImages: pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 184
Apoptotic mechanisms in mutant LRRK2-mediated cell death 184
Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients 183
Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease? 183
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 183
Electrophysiological comparison between males and females in HNPP 182
Cervico-oculo-Acoustic syndrome in a male with consanguineous parents 182
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease 182
Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait 181
Gait Patterns in Parkinsonian Patients With or Without Mild Cognitive Impairment 181
Season of birth and Parkinson's disease: possible relationship? 180
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy 179
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 178
Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease. 177
Cognitive dysfunctions in occipital lobe epilepsy compared to temporal lobe epilepsy. 175
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease 175
Neuropsychological profile of adult patients with non symptomatic occipital lobe epilepsies 174
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 174
The "eye of the tiger" sign in pure akinesia with gait freezing 173
Normative data for the Montreal Cognitive Assessment in an Italian population sample 172
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders. 172
Gender and non motor fluctuations in Parkinson's disease: A prospective study 170
Early MRI findings in Acquired hepatocerebral degeneration 169
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease 169
The closing-in phenomenon in Parkinson's disease 169
Impulse control disorders and cognitive dysfunctions in patients with Parkinson's disease 168
Uric acid relates to dopamine transporter availability in Parkinson's disease 168
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 167
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2 166
Hemi-Restless Legs Syndrome induced by Clebopride 165
Linkage exclusion in Italian families with hereditary essential tremor 164
Comment on Poletti et al. “Affective theory of mind in patients with Parkinson's disease”. 163
Impulse Control Disorders induced by Rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 Cases 163
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 162
Unawareness of dyskinesias in Parkinson's and Huntington's diseases 161
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease 160
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 160
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease 159
Link between non-motor symptoms and cognitive dysfunctions in de-novo, drug naïve PD patients 158
Cognitive Dysfunctions and Pathological Gambling in Patients with Parkinson’s Disease 157
The relationship between cerebral vascular disease and parkinsonism: the VADO study 157
Hearing impairment in Parkinson’s disease: expanding non motor phenotype 155
No evidence of association between CAG expansions and essential tremor in a large cohort of Italian patients 155
Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease 155
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study 154
Cortical thickness in Parkinsonians with impulse control disorders: A comment 152
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study. 152
Ping-pong gaze: Sherrington would not have done it better 151
Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease 151
Mild Cognitive Impairment in drug-naïve PD patients is associated with cerebral hypometabolism 149
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 149
Quitting smoking: an early non-motor feature of Parkinson's disease? 148
Pallidal stimulation in atypical pantothenate kinase-associated neurodegeneration: six-year follow-up 148
The role of Vitamin D levels on neuropsychological profile of patients with Parkinson’s Disease 147
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 145
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 142
Totale 18.825
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.309
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020433 0 0 0 0 0 0 0 0 0 107 279 47
2020/20213.202 267 88 336 187 426 105 337 39 148 241 136 892
2021/20221.528 189 151 44 402 84 102 163 120 98 95 50 30
2022/20232.611 310 164 143 315 236 436 106 312 312 75 150 52
2023/20241.229 91 44 449 46 26 106 32 81 171 61 18 104
2024/20253.901 61 360 26 109 96 401 1.121 1.358 336 33 0 0
Totale 25.027